T2 weighted-based radiomics proved superior in classification performance than qualitative assessment and diffusion-weighted (DW) imaging for diagnosing pathologic complete response (pCR) in patients with rectal cancer who received therapy prior to their main treatment, according to a March 8 study in Radiology.
Zika virus has had a significant impact in North and South America, most notably by causing microcephaly in babies born to infected mothers. But Brazilian researchers have found the deadly virus may be an effective treatment for glioblastoma—the most common and aggressive form of malignant brain tumor in adults.
In patients with early-stage breast cancer, neoadjuvant chemotherapy (NAC) is a common treatment to reduce tumor size before surgery. A team has found dynamic diffuse optical tomography (DDOT) can detect if a tumor has responded to chemotherapy within two weeks of initial treatment—potentially life-saving information for patients.
Pairing ultrasound with a blood test to detect high alpha fetoprotein (AFP) levels demonstrated up to a 40 percent improvement in detecting early-stage liver cancer, according to new research published in the journal Gastroenterology.
Breast cancer is the most common form of cancer among women. And a new study finds injecting oxygen-filled microbubbles into breast cancer makes tumors three times more responsive to radiation treatment, according to an International Journal of Radiation Oncology study.
High rates of incidental findings, limited risk-reward outcomes and unnecessary emotional stress suggest to one group of authors that lung cancer screening efforts need to be refined and the risk and benefits clearly communicated to better screen high-risk patients.
Five years ago the American Society of Clinical Oncology (ASCO) advised clinicians not to order advanced imaging or tumor marker tests for survivors of early-stage breast cancer. Yet the exam orders keep coming.
Reviewing brain MRI of close to 4,000 children as part of an ongoing population-based study, European neuroradiologists and neuroscientists discovered at least one incidental finding in more than one-quarter of the cohort.
The National Academy of Medicine announced Monday, Oct. 17, that it elected 80 new members, including Deborah Watkins Bruner, RN, PhD, a professor of radiation oncology at Emory University in Atlanta.